Cargando…

Can vitamin D status influence seroconversion to SARS-COV2 vaccines?

Existing data indicate an association between vitamin D deficiency and increased severity of respiratory distress due to COVID-19 infection, especially in high-risk populations. To date, the effect of vitamin D on immunogenicity to SARS-CoV-2 vaccines has been investigated solely in young healthcare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahini, Endrit, Pesce, Francesco, Argentiero, Antonella, Solimando, Antonio Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806423/ https://www.ncbi.nlm.nih.gov/pubmed/36601112 http://dx.doi.org/10.3389/fimmu.2022.1038316

Ejemplares similares

Corrigendum: Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
por: Shahini, Endrit, et al.
Publicado: (2023)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting
por: Solimando, Antonio G., et al.
Publicado: (2023)

Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion
por: Jay, Cecilia, et al.
Publicado: (2023)

Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review
por: Shahini, Endrit, et al.
Publicado: (2023)

Chronic functional constipation is strongly linked to vitamin D deficiency
por: Panarese, Alba, et al.
Publicado: (2019)

Determinants of COVID-19 Disease Severity–Lessons from Primary and Secondary Immune Disorders including Cancer
por: Solimando, Antonio G., et al.
Publicado: (2023)

Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence
por: Esposito, Susanna, et al.
Publicado: (2022)

Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer
por: Passardi, Alessandro, et al.
Publicado: (2023)

Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients
por: Patelli, Giorgio, et al.
Publicado: (2022)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Risk Factors Influencing Seroconversion after Inactive SARS-CoV-2 Vaccination in People Living with Obesity
por: Kara, Zehra, et al.
Publicado: (2022)

Vitamin D status and seroconversion for COVID-19 in UK healthcare workers
por: Faniyi, Aduragbemi A., et al.
Publicado: (2021)

Myocarditis Following COVID-19 Vaccine Use: Can It Play a Role for Conditioning Immunization Schedules?
por: Esposito, Susanna, et al.
Publicado: (2022)

Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV
por: Wang, Yi, et al.
Publicado: (2023)

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
por: Spencer, Elizabeth A, et al.
Publicado: (2021)

Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
por: Trontzas, Ioannis P., et al.
Publicado: (2022)

Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Influences of Vitamin A on Vaccine Immunogenicity and Efficacy
por: Penkert, Rhiannon R., et al.
Publicado: (2019)

Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center
por: Prasad, Narayan, et al.
Publicado: (2022)

Surveillance strategies for precancerous gastric conditions after Helicobacter pylori eradication: There is still need for a tailored approach
por: Shahini, Endrit, et al.
Publicado: (2021)

SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
por: Anft, Moritz, et al.
Publicado: (2023)

SARS-CoV-2 antibody seroconversion in care home
por: Shang, Joan, et al.
Publicado: (2020)

Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review
por: Brunetti, Oronzo, et al.
Publicado: (2019)

Impaired seroconversion after SARS-CoV-2 mRNA vaccine in patients with thymic epithelial tumors
por: Pietroluongo, Erica, et al.
Publicado: (2023)

189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer
por: Trontzas, I.P., et al.
Publicado: (2022)

Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination
por: Guven, Deniz C, et al.
Publicado: (2022)

On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination
por: Fernandes-Siqueira, Lorena O., et al.
Publicado: (2022)

Seroconversion among rituximab-treated patients following SARS-CoV-2 vaccine supplemental dose
por: Rose, Emily, et al.
Publicado: (2022)

SARS-Cov-2 Infection and Seroconversion Rates in Healthcare Providers Prior to COVID-19 Vaccine Rollout
por: Shin, Sanghyuk S., et al.
Publicado: (2023)

Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment
por: Takahashi, Keita, et al.
Publicado: (2021)

Seroconversion stages COVID19 into distinct pathophysiological states
por: Galbraith, Matthew D, et al.
Publicado: (2021)

Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis
por: Shahini, Endrit, et al.
Publicado: (2022)

Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants
por: Alfano, Gaetano, et al.
Publicado: (2021)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered
por: López-Cortés, Luis F., et al.
Publicado: (2023)

Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose
por: Rossi, Andres H., et al.
Publicado: (2021)

Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis
por: Nemeth, Dora, et al.
Publicado: (2022)

Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection
por: Abu Shanap, Mayada, et al.
Publicado: (2022)

Healthcare Worker Seroconversion in SARS Outbreak
por: Chow, Pierce K. H., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_5c83tktbutjdklh2se8a45n0d7